EcoDrugPlus

Adrenoceptor Alpha 1d

Ensembl ID : ENSSLDG00000004332
Gene Symbol: ADRA1D
3 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSSLDG00000012255
Gene Symbol: ADRA2A
3 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSSLDG00000017338
Gene Symbol: ADRA2A
3 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSSLDG00000001359
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSSLDG00000012432
Gene Symbol: ADRA2C
4 Cross references
157 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSSLDG00000006347
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSSLDG00000005630
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSSLDG00000003082
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSSLDG00000012569
Gene Symbol: LOC111663697
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSSLDG00000010243
Gene Symbol: LOC111671295
3 Cross references
344 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSSLDG00000012530
Gene Symbol: LOC111663629
3 Cross references
344 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSSLDG00000023298
Gene Symbol: GAA
2 Cross references
233 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).